The Lack of HER-2/neu Oncogene Amplification in Colorectal Malignancies
暂无分享,去创建一个
S. Yoshida | A. Ohtsu | N. Boku | F. Oberti | K. Okuyama | P. Calès | A. Croué | J. Okami | P. Burtin | K. Maruyama | A. Strunz | T. Ohmori | S. Dohn | R. Benoît | K. Yoshino | Meyer | H. Ishii | P. Bohlmann | Boyer J. Endoscopic | Monden M. Up
[1] H. Stein,et al. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis , 2003, British Journal of Cancer.
[2] S. Yoshida,et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. , 2002, Gastrointestinal endoscopy.
[3] H. Stein,et al. Screening for oesophageal neoplasia in patients with head and neck cancer , 2002, British Journal of Cancer.
[4] M. Sliwkowski,et al. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. , 2001, Gastroenterology.
[5] Y. Doki,et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] H. Makuuchi,et al. Survival Benefit of Screening for Early Esophageal Carcinoma in Head and Neck Cancer Patients , 1998 .
[7] F. Oberti,et al. Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? , 1997, Gastrointestinal endoscopy.
[8] K. Pavelić,et al. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. , 1997, Gastroenterology.
[9] K. Okuyama,et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining , 1995, Cancer.
[10] M. Thun. NSAIDs and esophageal cancer: ready for trials but not yet broad clinical application. , 2003, Gastroenterology.
[11] A. Potti,et al. HER-2/neu overexpression in colonic malignancies. , 2002, Gastroenterology.